InvestSMART

Teva Pharmaceutical Industries Limited (NYSE: TEVA) - Share Price

Current share price for TEVA : $42.090 0.62 (1.50%)+

Currency: USD ($)

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

TEVA General Information +

NYSE Code TEVA
Industry/Sector Drug Manufacturers - Specialty & Generic
Market Cap ($M) 49,047
TEVA Share Price $42.090
Day High $42.540
Day Low $41.230
Last Close $41.470
TEVA Share Price Movement $0.62 ( 1.50% )
Prices as at 3:42, 31 Oct 2026
+Security prices are at best end-of-day and are indicative only.

TEVA Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
$14.85 $2.84 $36.36 1.45% 69.12 n/a n/a 7.45

TEVA Calendar of Events

Created Date Changed Date Event
14 September 2026 14 September 2026 Security Re-classification

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.